Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Cook

Showing results (271-280 of 329) with videos related to

Pageof 33
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 30, 2018
A novel GABA<sub>A</sub> receptor ligand MIDD0301 with limited blood-brain barrier penetration relaxes airway smooth muscle ex vivo and in vivoGene T Yocum, Jose F Perez-Zoghbi, Jennifer Danielsson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2006
Dopamine and benzodiazepine-dependent mechanisms regulate the EtOH-enhanced locomotor stimulation in the GABAA alpha1 subunit null mutant miceHarry L June, Katrina L Foster, William J A Eiler, et al.
Pharmaceutics|March 27, 2025
Parenteral Nanoemulsion for Optimized Delivery of GL-II-73 to the Brain-Comparative In Vitro Blood-Brain Barrier and In Vivo Neuropharmacokinetic EvaluationKristina Jezdić, Jelena Đoković, Ivan Jančić, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's diseaseChristopher J Helal, Zhijun Kang, John C Lucas, et al.
Drug Development Research|March 5, 2022
Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomerM S Rashid Roni, Nicolas M Zahn, Gene T Yocum, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 2023
Vascular effects of midazolam, flumazenil, and a novel imidazobenzodiazepine MP-III-058 on isolated rat aortaMilica Gajić Bojić, Marco Treven, Kamal P Pandey, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2018
Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABA<sub>A</sub> Receptor Subtypes: Quantitative Observation Studies in Rhesus MonkeysAngela N Duke, Zhiqiang Meng, Donna M Platt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
The GABA(A) receptor alpha1 subtype in the ventral pallidum regulates alcohol-seeking behaviorsScott C Harvey, Katrina L Foster, Pete F McKay, et al.
Alcoholism, Clinical and Experimental Research|September 1, 2005
Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcoholJason B Cook, Katrina L Foster, William J A Eiler, et al.
Basic & Clinical Pharmacology & Toxicology|January 30, 2019
MIDD0301 - A first-in-class anti-inflammatory asthma drug targets GABA<sub>A</sub> receptors without causing systemic immune suppressionNicolas M Zahn, Alec T Huber, Brandon N Mikulsky, et al.
Pageof 33

Showing results (271-280 of 329) with videos related to

Sort By:
Pageof 33
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 30, 2018
A novel GABA<sub>A</sub> receptor ligand MIDD0301 with limited blood-brain barrier penetration relaxes airway smooth muscle ex vivo and in vivoGene T Yocum, Jose F Perez-Zoghbi, Jennifer Danielsson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2006
Dopamine and benzodiazepine-dependent mechanisms regulate the EtOH-enhanced locomotor stimulation in the GABAA alpha1 subunit null mutant miceHarry L June, Katrina L Foster, William J A Eiler, et al.
Pharmaceutics|March 27, 2025
Parenteral Nanoemulsion for Optimized Delivery of GL-II-73 to the Brain-Comparative In Vitro Blood-Brain Barrier and In Vivo Neuropharmacokinetic EvaluationKristina Jezdić, Jelena Đoković, Ivan Jančić, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's diseaseChristopher J Helal, Zhijun Kang, John C Lucas, et al.
Drug Development Research|March 5, 2022
Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomerM S Rashid Roni, Nicolas M Zahn, Gene T Yocum, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 2023
Vascular effects of midazolam, flumazenil, and a novel imidazobenzodiazepine MP-III-058 on isolated rat aortaMilica Gajić Bojić, Marco Treven, Kamal P Pandey, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2018
Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABA<sub>A</sub> Receptor Subtypes: Quantitative Observation Studies in Rhesus MonkeysAngela N Duke, Zhiqiang Meng, Donna M Platt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
The GABA(A) receptor alpha1 subtype in the ventral pallidum regulates alcohol-seeking behaviorsScott C Harvey, Katrina L Foster, Pete F McKay, et al.
Alcoholism, Clinical and Experimental Research|September 1, 2005
Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcoholJason B Cook, Katrina L Foster, William J A Eiler, et al.
Basic & Clinical Pharmacology & Toxicology|January 30, 2019
MIDD0301 - A first-in-class anti-inflammatory asthma drug targets GABA<sub>A</sub> receptors without causing systemic immune suppressionNicolas M Zahn, Alec T Huber, Brandon N Mikulsky, et al.
Pageof 33